Need for Uniform Standards Covering UV-C Based Antimicrobial Disinfection Devices

On June 26, 2014, the U.S. House Subcommittee on Research and Technology described HAIs as the most common complication of hospital care, citing the Centers for Disease Control and Prevention (CDC) estimates that HAIs cause or contribute to as many as 99,000 deaths annually.1 More recently, the CDC...

Full description

Saved in:
Bibliographic Details
Published in:Infection control and hospital epidemiology 2016-08, Vol.37 (8), p.1000-1001
Main Author: Cowan, Troy E.
Format: Article
Language:English
Subjects:
Bacteria
Cross Infection - prevention & control
Disinfection & disinfectants
Disinfection - instrumentation
Disinfection - standards
Environmental protection
Health care industry
Hospitals
Letters to the Editor
Nursing
Occupational health
Pathogens
Prevention
Research methodology
Scientists
Staphylococcus infections
Ultraviolet radiation
Ultraviolet Rays
United States
United States Environmental Protection Agency
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:On June 26, 2014, the U.S. House Subcommittee on Research and Technology described HAIs as the most common complication of hospital care, citing the Centers for Disease Control and Prevention (CDC) estimates that HAIs cause or contribute to as many as 99,000 deaths annually.1 More recently, the CDC stated that 1 in every 25 hospital patients will be treated for an HAI.2 The 2 most difficult pathogens to prevent are Clostridium difficile (C.diff), which causes nearly 20,000 deaths per year,3 and methicillin-resistant Staphylococcus aureus (MRSA), which causes nearly 19,000 deaths per year.4 Both are preventable with antimicrobial UV-C devices. UV-C Ultraviolet Light Technology Transition UV-C kills HAI pathogens, with maximum bactericidal effect at a wavelength of 250 nm. The Challenge Do the medical experts performing the peer reviews or scientists who perform the studies, the hospital administrators or the third-party scientists, industry representatives or even the EPA have a responsibility to step up and take an action advocating and implementing UV-C efficacy standards? “Professional organizations in infection prevention and occupational health are well positioned to take leadership in this effort by establishing joint committees and engaging with funders to set priorities and a time table to move the research and improved practice guidance forward.”
ISSN:0899-823X
1559-6834
DOI:10.1017/ice.2016.130